四川新斯顿

Sichuan Xinsidun Pharmaceutical is a comprehensive pharmaceutical enterprise based in Chengdu, China, dedicated to the R&D, production, and sale of chemical drugs. The company maintains a diverse product portfolio that addresses major therapeutic needs in cardiovascular diseases, anti-infectives, and gastroenterology. With a focus on high-quality generic medications, Xinsidun has successfully navigated China's consistency evaluation process for several key products, ensuring bioequivalence to brand-name drugs. The company operates large-scale manufacturing facilities that are GMP-certified for various dosage forms including tablets, capsules, and granules. Xinsidun is listed on China's National Equities Exchange and Quotations (NEEQ), reflecting its established position in the domestic market.